Log in Free sign up

Global Cord Blood (CO) News and press releases

News

From Benzinga Pro

5 Value Stocks In The Healthcare Sector

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

5 Value Stocks In The Healthcare Sector

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease

Biotech, Large Cap, News, Penny Stocks, Health Care, Small Cap, FDA, General

Here's a roundup of top developments in the biotech space over the last 24 hours:

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by 34.4% to $2.81 during Thursday's after-market session. The market value of their outstanding shares is at $29.0 million.

Global Cord Blood Stock Gains As FDA Announced Clearance To Study Blood Cancer Candidate

Penny Stocks, Health Care, Small Cap, General

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance Of IND Application For CK0804 As Add On Therapy To Ruxolitinib For The Treatment Of Myelofibrosis

Global Cord Blood Corporation (NYSE:CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell

5 Value Stocks To Watch In The Healthcare Sector

The Meaning Behind Value Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Pre-Market Outlook, Markets, Movers

69 Biggest Movers From Friday

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Global Cord Blood Shareholder Blue Ocean Offers Comment On Fraud Claims: 'Recent Filing Only Intended as a Distraction to Shareholders and has No Impact on Blue Ocean Campaign to STOP the Cellenkos Transaction'

News, Hedge Funds, Management, General

Blue Ocean Structure Investment Company Ltd. (“Blue Ocean”), a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE:CO), today commented on

How Is The Market Feeling About Global Cord Blood?

Short Sellers, Short Ideas, Trading Ideas

Global Cord Blood's (NYSE:CO) short percent of float has risen 23.08% since its last report. The company recently reported that it has 48.00 thousand shares sold short, which is 0.16% of all regular shares that are available for trading.

Press releases

From Benzinga Pro

Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

HONG KONG, July 6, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE:CO, ", GCBC", or the ", Company", )), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

Earnings, Press Releases

Added 16,423 New Subscribers in 4QFY22 4QFY22 Revenues Down 1.7% YoY to RMB297.2 Million ($46.9 Million) 4QFY22 Gross Profit Down 0.5% YoY to RMB255.2 Million ($40.3 Million) 4QFY22 Operating Income Down 4.1% YoY to

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

HONG KONG, June 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE:CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem

Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation

Blue Ocean Structure Investment Company Ltd., ("Blue Ocean") and shareholders representing over 75% of the outstanding shares of Global Cord Blood Corporation (the "Company" or "Global Cord") (NYSE:CO) today announced

Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened

HONG KONG, June 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE:CO, ", GCBC", or the ", Company", )), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem

Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights

Blue Ocean Structure Investment Company Ltd.,("Blue Ocean") together with shareholders representing no less than 75% of the outstanding shares of Global Cord Blood Corporation (the "Company" or "Global Cord") (NYSE:CO)

Shareholders Led by Blue Ocean Call Extraordinary General Meeting of Global Cord Blood Corporation Shareholders to Terminate its Proposed Acquisition of Cellenkos, Inc. and Elect New Board

Blue Ocean Structure Investment Company Ltd.,("Blue Ocean") announced today that shareholders representing no less than 75% of the outstanding shares of Global Cord Blood Corporation (the "Company" or "Global Cord")

Blue Ocean Announces Virgin Islands Court Grants Injunction Order Prohibiting Golden Meditech from Taking Any Steps on a Purported Share Charge from Blue Ocean or Pursuing the Removal of Blue Ocean's Representative as a Director of Global Cord Blood

Blue Ocean Structure Investment Company Ltd. ("Blue Ocean"), a significant shareholder of Global Cord Blood Corporation (the "Company" or "Global Cord") (NYSE:CO), today announced that the Eastern Caribbean Supreme

Blue Ocean Comments on Fraudulent Claims from Conflicted Party Golden Meditech Regarding Global Cord Blood Corporation

Recent Filing Only Intended as a Distraction to Shareholders and has No Impact on Blue Ocean Campaign to STOP the Cellenkos Transaction Blue Ocean Structure Investment Company Ltd. ("Blue Ocean"), a significant